Back to Authors

Katz, Eva G.

https://orcid.org/0000-0002-6293-1674

A5016442402 | I4405282460

Mayo Clinic

Janssen Research & Development (United States)

Citations 1

Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma

New England Journal of Medicine | December 9, 2024 | Volume: 392 | Issue: 18 | Pages: 1777-1788

10.1056/nejmoa2409029 | PMID 39652675